Therapy for elderly patients with advanced non-small cell lung cancer
10.3760/cma.j.issn.1673-422X.2018.12.012
- VernacularTitle:老年晚期非小细胞肺癌患者的治疗
- Author:
Jin ZHOU
1
;
Jie WU
;
Huibo ZHANG
;
Min CHEN
Author Information
1. 430060,武汉大学人民医院肿瘤科
- Keywords:
Carcinoma,non-small-cell lung;
Aged;
Antineoplastic protocols
- From:
Journal of International Oncology
2018;45(12):756-759
- CountryChina
- Language:Chinese
-
Abstract:
Chemotherapy is recommended for stage Ⅲ B/ Ⅳ non-small cell lung cancer (NSCLC) treatment.The treatments for elderly patients with advanced NSCLC are mainly single-agent chemotherapy and platinum-based combination chemotherapy.However,elderly patients tolerate chemotherapy poorly because of agerelated comorbidities.Therefore,the curative effect of elderly patients is relatively poorer as compared to their younger counterparts.Targeted therapy and immune therapy have become new research directions.It is important to select an appropriate program for elderly patients according to geriatric assessments.
